High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients—A Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) analysis

Publication | Closed Access

DOI

Citations

References

2008

Year

Amir Lotfi, Marc J. Schweiger, Gregory Giugliano, Sabina A. Murphy, Christopher P. Cannon

American Heart Journal

ThrombosisCardiovascular DiseaseHigh-dose AtorvastatinMyocardial Infarction 22Clinical OutcomesPharmacotherapyPlatelet AntagonistMedicineCardiologyCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction